| 产品描述: | Bragsin2 is a potent, selective and noncompetitive nucleotide exchange factor BRAG2 inhibitor, with an IC50 of 3 μM. Bragsin2 binds at the interface between the PH domain of BRAG2 and the lipid bilayer, leads BRAG2 unable to activate lipidated Arf GTPase. Bragsin2 affects breast cancer stem cells |
| 靶点: |
IC50: 3 μM (BRAG2) |
| 体外研究: |
Bragsin2 (50 μM) inhibits Arf GTPase activation in HeLa cells. Bragsin2 (50 μM) inhibits the growth of SUM149 and S68, with no effect on SUM159, which lacks adhesion molecules such as integrins and cadherins. |
| 参考文献: |
1. Nawrotek A, et al. PH-domain-binding inhibitors of nucleotide exchange factor BRAG2 disrupt Arf GTPase signaling. Nat Chem Biol. 2019 Feb 11. doi: 10.1038/s41589-019-0228-3. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.458 ml |
17.291 ml |
34.583 ml |
| 5 mM |
0.692 ml |
3.458 ml |
6.917 ml |
| 10 mM |
0.346 ml |
1.729 ml |
3.458 ml |
| 50 mM |
0.069 ml |
0.346 ml |
0.692 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |